Browsing Tag
Therapeutics
4 posts
Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer
Tucson, AZ, February 10, 2024 --(PR.com)-- Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic potential of ultrasound, proudly announces the appointment of Dr Thom Tulip as their new Chief Business Officer. In this pivotal role, Dr Tulip will lead capital raises to propel
February 10, 2024
Pear Therapeutics: Bankruptcy judge approves sale of assets
Skip to main content Pear Therapeutics' assets were sold for about $6 million Monday to four companies, including one with ties to its former CEO. At a hearing in U.S. Bankruptcy Court for the District of Delaware, Judge Thomas Horan ruled that Click Therapeutics, Nox Health, Welt and Harvest Bio can proceed with the formal sales process.
May 22, 2023
JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building
SHANGHAI, Jan. 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, recently announced the appointments of Dr. Shaun Paul Cordoba as Chief Scientific Officer (CSO) and Raymond J. Hage, Jr. as Senior Vice President (SVP) of Corporate Development. In the newly created…
January 10, 2022
The Rise of RNA Therapeutics
Most American newborns will arrive home from the hospital and start hitting their developmental milestones, to their parents’ delight. They will hold their heads up by about three months. They will sit up by six. And they will walk around their first birthday. But about 1 in 10,000 will not. They will feel limp in…
September 29, 2021